HomeHeadlinesUS FDA has agreed to reverse the rejection of Regenxbio's (RGNX) experimental gene therapy Navsunli, WSJ reports citing sourcesJUNE 22, 2026 AT 10:30 AMUS FDA has agreed to reverse the rejection of Regenxbio's (RGNX) experimental gene therapy Navsunli, WSJ reports citing sourcesByNewsquawk StaffTrade the TapeGet this analysis live, the moment it breaksNewsquawk's real-time dashboard delivers market-moving headlines and instant context to your desk before the rest of the market reacts.Open Dashboard#FDA#EU SESSION#US EQUITIES
JUNE 22, 2026 AT 10:30 AMUS FDA has agreed to reverse the rejection of Regenxbio's (RGNX) experimental gene therapy Navsunli, WSJ reports citing sourcesByNewsquawk StaffTrade the TapeGet this analysis live, the moment it breaksNewsquawk's real-time dashboard delivers market-moving headlines and instant context to your desk before the rest of the market reacts.Open Dashboard#FDA#EU SESSION#US EQUITIES
